FDA 483 - Oy Finnsusp Ab - April 03, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Oy Finnsusp Ab, an OTC drug manufacturer in Lieto, Finland, was inspected and cited for significant deficiencies across multiple systems. Observations included inadequate batch production records, failure to prevent contamination in the water system, deficient OOS investigations, and issues with reserve sample management. Additionally, the firm failed to follow procedures for preventing microbiological contamination in sterile drug production and lacked equivalent visual inspection procedures.
ID · 6f299c4a-fd9a-4a8f-aa82-30ad92d3cbf3